𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life

✍ Scribed by V. Puente; O. De Fabregues; C. Oliveras; G. Ribera; C. Pont-Sunyer; R. Vivanco; G. Cucurella; E. Giralt; T. Delgado; C. Garcia; A. Seoane; R. Campo

Book ID
116820695
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
120 KB
Volume
16
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Study of istradefylline in patients with
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
✍ Robert A. Hauser; Lisa M. Shulman; Joel M. Trugman; John W. Roberts; Akihisa Mor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a

Intrajejunal levodopa infusion in Parkin
Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life
✍ Holger Honig; Angelo Antonini; Pablo Martinez-Martin; Ian Forgacs; Guy C. Faye; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Abstract Switching from oral medications to continuous infusion of levodopa/carbidopa gel reduces motor complications in advanced Parkinson's disease (PD), but effects on nonmotor symptoms (NMSs) are unknown. In this prospective open‐label observational study, we report the effects of intrajejun